Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5

BNT162b2-vaccinated individuals after Omicron BA.1 breakthrough infection have strong serum neutralizing activity against Omicron BA.1, BA.2, and previous SARS-CoV-2 variants of concern (VOCs), yet less against the highly contagious Omicron sublineages BA.4 and BA.5 that have displaced previous vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Muik, Alexander, Lui, Bonny Gaby, Bacher, Maren, Wallisch, Ann-Kathrin, Toker, Aras, Finlayson, Andrew, Krüger, Kimberly, Ozhelvaci, Orkun, Grikscheit, Katharina, Hoehl, Sebastian, Ciesek, Sandra, Türeci, Özlem, Sahin, Ugur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529054/
https://www.ncbi.nlm.nih.gov/pubmed/36125366
http://dx.doi.org/10.1126/sciimmunol.ade2283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529054/
https://www.ncbi.nlm.nih.gov/pubmed/36125366
http://dx.doi.org/10.1126/sciimmunol.ade2283

Ejemplares similares